PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Rituximab - Refractory vasculitis

PAD Profile : Rituximab - Refractory vasculitis

Keywords :
Vasculitis
Brand Names Include :
MabThera

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NHSE
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

Type
Document
Review Date
NICE Technology Appraisal

Committee Recommendations

Date
Committee Name
Narrative
02 April 2014
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Commissioned by NHS England. Treatment should be initiated by the specialist and is considered to be a RED drug on the traffic light system. GPs should not be requested to prescribe this treatment
01 April 2013
Not Set
Funded by NHS England from 1st April 2013. Treatment should remain with the specialist (RED) hospital only drug.

Associated BNF Codes

10. Musculoskeletal and Joint Diseases
10.01.03. Rheumatic disease suppressant drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More